ImmunityBio , a leading immunotherapy company, announced today that the European Medicines Agency has recommended granting a conditional marketing authorization in the EU for ANKTIVA® (nogapendekin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback